TLDR
- ARK Invest bought 283,022 CoreWeave shares on November 12, even after the stock fell 6.9%.
- The firm sold 58,339 Palantir shares and 15,941 Amazon shares the same day.
- Palantir beat revenue estimates, but its total contract value growth slowed to 6%.
- ARK also bought Twist Bioscience, Archer Aviation, Kratos Defense and Rocket Lab.
- Analysts see 83.9% upside for CoreWeave, 33.5% for Palantir and 21.5% for Amazon.
Cathie Wood’s ARK Invest added to its CoreWeave position on Thursday, November 12. The firm also sold shares of Palantir Technologies and Amazon on the same day.
CoreWeave, Inc. Class A Common Stock, CRWV
ARK’s daily trade disclosures show it bought 283,022 CoreWeave shares across its ARKK and ARKW funds. The purchase was worth about $16 million to $17 million, depending on the price used.
ARK Buys CoreWeave After a Sharp Swing
CoreWeave stock fell 6.9% on November 12. A day earlier, it had jumped 24.7% after the company reported third-quarter results.
Revenue rose 168% from a year earlier to $3.66 billion. CoreWeave also raised its 2026 revenue forecast to a range of $13 billion to $13.3 billion.
The company’s backlog reached $132.5 billion. It also lifted its year-end 2026 annual recurring revenue outlook to between $20 billion and $21 billion.
CoreWeave expects to receive $9 billion in customer prepayments and deposits over the next three months. CEO Michael Intrator said the funding will help build and expand the AI infrastructure and software its customers need.
Palantir and Amazon Sales Follow Earnings News
ARK sold 58,339 Palantir shares on Thursday, worth about $10 million. The sale was split between the ARKK and ARKW funds.
Palantir’s third-quarter revenue rose 96% to $2.31 billion, above the $2.18 billion Wall Street expected. Adjusted earnings were $0.44 per share, compared with the $0.41 estimate.
The company raised its 2026 revenue guidance to about $8.53 billion, which implies roughly 91% annual growth. Total contract value rose just 6% to $2.92 billion, after growing 49% in the prior quarter. Palantir shares have fallen nearly 18% over the past month.
ARK also sold 15,941 Amazon shares through its ARKK fund, worth about $4.2 million. That followed a sale of 10,968 shares on November 10, bringing the two sales to 26,909 shares worth about $7.3 million.
As of September 30, Amazon reported a fair value of $146.2 billion for its Anthropic convertible notes. It also reported $92.5 billion in nonvoting preferred stock and plans to hire more than 300,000 U.S. workers for the holiday season.
ARK bought 72,834 Twist Bioscience shares for $8.93 million across its ARKK and ARKG funds. It also bought 180,561 Archer Aviation shares across three funds, worth $877,526, continuing a week of steady buying.
The firm purchased 46,521 Kratos Defense & Security Solutions shares for $1.71 million. It also bought 15,114 Rocket Lab shares for about $1 million and 39,090 Scribe Therapeutics shares for $659,057.
On the selling side, ARK sold 230,040 BYD shares for about $2 million, extending a week of sales. It also sold 80,989 Tempus AI shares across its ARKK and ARKG funds for $6.43 million.
TipRanks data shows Amazon holds a Strong Buy consensus, while CoreWeave and Palantir hold a Moderate Buy. The average analyst price target implies 83.9% upside for CoreWeave, 33.5% for Palantir and 21.5% for Amazon.
